TECX (Tectonic Therapeutic) Cash-to-Debt : 42.76 (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Tectonic Therapeutic Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Tectonic Therapeutic's cash to debt ratio for the quarter that ended in Dec. 2024 was 42.76.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Tectonic Therapeutic could pay off its debt using the cash in hand for the quarter that ended in Dec. 2024.

The historical rank and industry rank for Tectonic Therapeutic's Cash-to-Debt or its related term are showing as below:

TECX' s Cash-to-Debt Range Over the Past 10 Years
Min: 6.21 Med: 16.61 Max: 42.76
Current: 42.76

During the past 4 years, Tectonic Therapeutic's highest Cash to Debt Ratio was 42.76. The lowest was 6.21. And the median was 16.61.

TECX's Cash-to-Debt is ranked better than
69.52% of 1483 companies
in the Biotechnology industry
Industry Median: 7.42 vs TECX: 42.76

Tectonic Therapeutic Cash-to-Debt Historical Data

The historical data trend for Tectonic Therapeutic's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Tectonic Therapeutic Cash-to-Debt Chart

Tectonic Therapeutic Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Cash-to-Debt

26.60

6.21

6.62

42.76

Tectonic Therapeutic Quarterly Data
	Dec21	Sep22	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
Cash-to-Debt	Get a 7-Day Free Trial				1.33	6.62	53.75	53.32	42.76

Competitive Comparison of Tectonic Therapeutic's Cash-to-Debt

For the Biotechnology subindustry, Tectonic Therapeutic's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tectonic Therapeutic's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tectonic Therapeutic's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Tectonic Therapeutic's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Tectonic Therapeutic Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Tectonic Therapeutic's Cash to Debt Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	141.239	/	(2.784	+	0.519)
	=	42.76

Tectonic Therapeutic's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	141.239	/	(2.784	+	0.519)
	=	42.76

Tectonic Therapeutic (NAS:TECX) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Tectonic Therapeutic Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Tectonic Therapeutic's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Tectonic Therapeutic Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tectonic Therapeutic Inc (NAS:TECX) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

490 Arsenal Way, Suite 210, Watertown, MA, USA, 02472

Website

https://www.tectonictx.com

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.